ClinicalTrials.Veeva

Menu

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Enrolling

Conditions

Inflammatory Bowel Disease

Study type

Observational

Funder types

Other

Identifiers

NCT00904878
CCFA pregnancy Registry (Other Identifier)
CCFA Pregnancy Registry

Details and patient eligibility

About

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part of the CCFA Clinical Alliance. The aim of this study is to determine the effect of medication use and disease activity on the outcome of pregnancy among women with IBD up to 18 years from birth.

Full description

All pregnant women with IBD diagnosis who are taking biologics medicines and immunosuppressants will be entered in the study.

Enrollment

1,500 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female patients with confirmed IBD diagnoses who are pregnant and taking immunosuppressants and/or biologic therapy

Exclusion criteria

  • Pregnant female patients younger than 18 years of age
  • Confirmed multiple gestation

Trial contacts and locations

2

Loading...

Central trial contact

Nicole Arima; Jessica Lim

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems